capital’s

Legend Capital: The Logic of Technology Investment Has Changed

HONG KONG, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022. In addition, Legend Capital’s CRO portfolio company R&G Pharmastudies was successfully listed on the ChiNext of... » read more

Legend Capital enjoys 4 MedTech IPOs in 1H2021, focusing on long-term and innovation investment

HONG KONG, Sep 10, 2021 – (ACN Newswire via SEAPRWire.com) – Recently, Berry Oncology, a company focusing on genomic testing of cancers in China, announced the completion of a US$99.15 million Series B1 financing round, with Legend Capital’s continuous support. This B1 financing round was led by China Merchants Capital Management Co., Ltd. Existing investors... » read more